Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects
NCT02253342
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Intrapulmonary Pharmacokinetics of WCK 2349
Interventions
DRUG:
WCK-2349
Sponsor
Wockhardt
Collaborators
[object Object]